EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

CAR-T Therapy Beyond B-Cell Hematological Malignancies

Martina Canichella iD, Paolo de Fabritiis

Cells · 03.01.2025 · 14 (1) · 41

DOI: 10.3390/cells14010041 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 03.01.2025. Verfasst von Martina Canichella und 1 weiteren Autor:innen. Beteiligte Einrichtung: Hematology, St. Eugenio Hospital, ASL Roma2, 00144 Rome, Italy. Hauptthemen laut MEDLINE: Hematologic Neoplasms, Immunotherapy, Adoptive, Receptors, Chimeric Antigen. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite the advances of CAR-T cells in certain hematological malignancies, mostly from B-cell derivations such as non-Hodgkin lymphomas, acute lymphoblastic leukemia and multiple myeloma, a significant portion of other hematological and non-hematological pathologies can benefit from this innovative treatment, as the results of clinical studies are demonstrating. The clinical application of CAR-T in the setting of acute T-lymphoid leukemia, acute myeloid leukemia, solid tumors, autoimmune diseases and infections has encountered limitations that are different from those of hematological B-cell diseases. To overcome these restrictions, strategies based on different molecular engineering platforms have been devised and will be illustrated below. The aim of this manuscript is to provide an overview of the CAR-T application in pathologies other than those currently treated, highlighting both the limits and results obtained with these settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematologic NeoplasmsImmunotherapy, AdoptiveReceptors, Chimeric AntigenHumansB-LymphocytesT-LymphocytesAnimals

Stichwörter der Autor:innen

CAR-T in hematologyCAR-T in solid neoplasiainfectious and autoimmune diseasetumor immunosuppressiontumor microenvironment

Substanzen

Receptors, Chimeric Antigen

Autor:innen und Institutionen

  • Hematology, St. Eugenio Hospital, ASL Roma2, 00144 Rome, Italy.
  • Department of Biomedicina e Prevenzione, Tor Vergata University, 00133 Rome, Italy.

ORCID-Profile: Martina Canichella

Zitieren

APA

Canichella, M., & de Fabritiis, P. (2025). CAR-T Therapy Beyond B-Cell Hematological Malignancies. Cells, 14(1), 41. https://doi.org/10.3390/cells14010041

Vancouver

Canichella M, de Fabritiis P. CAR-T Therapy Beyond B-Cell Hematological Malignancies. Cells. 2025;14(1):41. doi:10.3390/cells14010041

BibTeX
@article{Canichella2025,
  author = {Canichella, Martina and de Fabritiis, Paolo},
  title = {CAR-T Therapy Beyond B-Cell Hematological Malignancies},
  journal = {Cells},
  year = {2025},
  volume = {14},
  number = {1},
  pages = {41},
  doi = {10.3390/cells14010041}
}
Kostenlos starten →